Stock listing

Frankfurt:086 Castle Biosciences, Inc. Aktie

German listing (Frankfurt) of Castle Biosciences, Inc. · home listing NASDAQ:CSTL

Follow Castle Biosciences, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CSTL

$33.80 USD +0.69 (+2.1%)

Close on Oct 15, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CSTL

Castle Biosciences, Inc. logo
Ticker
Frankfurt:086
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Castle Biosciences (NASDAQ:CSTL) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 4:30 PM ET

    Watch Transcript

  • Castle Biosciences (NASDAQ:CSTL) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 4:30 PM ET

    Watch Transcript

  • Castle Biosciences (NASDAQ:CSTL) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026

Oct 15, 2026

ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus

Oct 12, 2026

Late-Breaking EADV 2026 Data Support Use of DecisionDx®-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management

Sep 30, 2026

New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus

Sep 28, 2026

New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™

Sep 24, 2026

Castle Biosciences to Open New Laboratory Facility in Scottsdale

Sep 22, 2026

New Decision Modeling Study Demonstrates TissueCypher® Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus

Sep 15, 2026

JAAD Publication Shows Improved Performance of DecisionDx®-SCC

Sep 9, 2026

Castle Biosciences: Approved for Dual Listing on Nasdaq Texas

Aug 17, 2026

Castle Biosciences Reports Second Quarter 2026 Results

Jul 30, 2026

All Castle Biosciences, Inc. news

Decks

Castle Biosciences, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
47 in the last 12 months · 310 in all · newest Oct 15, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Jul 30, 2026
Decks
55 decks · latest Jul 30, 2026

Where Castle Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CSTL · Home listingNASDAQUnited StatesUSD
Frankfurt:086 · This pageFrankfurtGermanyEUR
BOATS:CSTLBOATSUnited StatesUSD
Tradegate:086TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Castle Biosciences, Inc.